Show simple item record

dc.contributor.authorCornell, Morna
dc.contributor.authorTechnau, Karl
dc.contributor.authorFairall, Lara
dc.contributor.authorWood, Robin
dc.contributor.authorMoultrie, Harry
dc.contributor.authorvan Cutsem, Gilles
dc.contributor.authorGiddy, Janet
dc.contributor.authorMohapi, Lerato
dc.contributor.authorEley, Brian
dc.contributor.authorMacPhail, Patrick
dc.contributor.authorProzesky, Hans
dc.contributor.authorRabie, Helena
dc.contributor.authorDavies, Mary-Ann
dc.contributor.authorMaxwell, Nicola
dc.contributor.authorBoulle, Andrew
dc.date.accessioned2010-10-08T22:22:50Z
dc.date.available2010-10-08T22:22:50Z
dc.date.issued2009-09
dc.identifier.citationMonitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration. 2009, 99 (9):653-60 S. Afr. Med. J.en
dc.identifier.issn0256-9574
dc.identifier.pmid20073292
dc.identifier.urihttp://hdl.handle.net/10144/112733
dc.description.abstractOBJECTIVES: To introduce the combined South African cohorts of the International epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) collaboration as reflecting the South African national antiretroviral treatment (ART) programme; to characterise patients accessing these services; and to describe changes in services and patients from 2003 to 2007. DESIGN AND SETTING: Multi-cohort study of 11 ART programmes in Gauteng, Western Cape, Free State and KwaZulu-Natal. SUBJECTS: Adults and children (<16 years old) who initiated ART with > or =3 antiretroviral drugs before 2008. RESULTS: Most sites were offering free treatment to adults and children in the public sector, ranging from 264 to 17,835 patients per site. Among 45,383 adults and 6,198 children combined, median age (interquartile range) was 35.0 years (29.8-41.4) and 42.5 months (14.7-82.5), respectively. Of adults, 68% were female. The median CD4 cell count was 102 cells/microl (44-164) and was lower among males than females (86, 34-150 v. 110, 50-169, p<0.001). Median CD4% among children was 12% (7-17.7). Between 2003 and 2007, enrolment increased 11-fold in adults and 3-fold in children. Median CD4 count at enrolment increased for all adults (67-111 cells/microl, p<0.001) and for those in stage IV (39-89 cells/microl, p<0.001). Among children <5 years, baseline CD4% increased over time (11.5-16.0%, p<0.001). CONCLUSIONS: IeDEA-SA provides a unique opportunity to report on the national ART programme. The study describes dramatically increased enrolment over time. Late diagnosis and ART initiation, especially of men and children, need attention. Investment in sentinel sites will ensure good individual-level data while freeing most sites to continue with simplified reporting.
dc.language.isoenen
dc.rightsArchived with thanks to South African Medical Journal = Suid-Afrikaanse tydskrif vir geneeskundeen
dc.subject.meshAdulten
dc.subject.meshAnti-Retroviral Agentsen
dc.subject.meshChilden
dc.subject.meshChild, Preschoolen
dc.subject.meshCohort Studiesen
dc.subject.meshCommunity Health Servicesen
dc.subject.meshDatabases, Factualen
dc.subject.meshFemaleen
dc.subject.meshHIV Infectionsen
dc.subject.meshHealth Promotionen
dc.subject.meshHealth Services Accessibilityen
dc.subject.meshHumansen
dc.subject.meshInfanten
dc.subject.meshMaleen
dc.subject.meshMiddle Ageden
dc.subject.meshPopulation Surveillanceen
dc.subject.meshPractice Guidelines as Topicen
dc.subject.meshProgram Evaluationen
dc.subject.meshSouth Africaen
dc.subject.meshYoung Adulten
dc.titleMonitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration.en
dc.contributor.departmentInfectious Disease Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town. morna@global.co.zaen
dc.identifier.journalSouth African Medical Journal = Suid-Afrikaanse tydskrif vir geneeskundeen
refterms.dateFOA2019-03-04T08:22:45Z
html.description.abstractOBJECTIVES: To introduce the combined South African cohorts of the International epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) collaboration as reflecting the South African national antiretroviral treatment (ART) programme; to characterise patients accessing these services; and to describe changes in services and patients from 2003 to 2007. DESIGN AND SETTING: Multi-cohort study of 11 ART programmes in Gauteng, Western Cape, Free State and KwaZulu-Natal. SUBJECTS: Adults and children (<16 years old) who initiated ART with > or =3 antiretroviral drugs before 2008. RESULTS: Most sites were offering free treatment to adults and children in the public sector, ranging from 264 to 17,835 patients per site. Among 45,383 adults and 6,198 children combined, median age (interquartile range) was 35.0 years (29.8-41.4) and 42.5 months (14.7-82.5), respectively. Of adults, 68% were female. The median CD4 cell count was 102 cells/microl (44-164) and was lower among males than females (86, 34-150 v. 110, 50-169, p<0.001). Median CD4% among children was 12% (7-17.7). Between 2003 and 2007, enrolment increased 11-fold in adults and 3-fold in children. Median CD4 count at enrolment increased for all adults (67-111 cells/microl, p<0.001) and for those in stage IV (39-89 cells/microl, p<0.001). Among children <5 years, baseline CD4% increased over time (11.5-16.0%, p<0.001). CONCLUSIONS: IeDEA-SA provides a unique opportunity to report on the national ART programme. The study describes dramatically increased enrolment over time. Late diagnosis and ART initiation, especially of men and children, need attention. Investment in sentinel sites will ensure good individual-level data while freeing most sites to continue with simplified reporting.


Files in this item

Thumbnail
Name:
Cornell_Monitoring the SA ART ...
Size:
341.1Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record